Flexion Therapeutics
FLXN
#6916
Rank
โ‚ฌ0.42 B
Marketcap
8,43ย โ‚ฌ
Share price
0.00%
Change (1 day)
8,175.24%
Change (1 year)

Revenue for Flexion Therapeutics (FLXN)

Revenue in 2021 (TTM): โ‚ฌ84.41 Million

According to Flexion Therapeutics 's latest financial reports the company's current revenue is โ‚ฌ92.78 Million. In 2020 the company made a revenue of โ‚ฌ79.06 Million an increase over the revenue in the year 2019 that were of โ‚ฌ67.42 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Flexion Therapeutics from 2018 to 2021

Annual revenue

Year Revenue Change
2021 (TTM)โ‚ฌ84.41 M6.77%
2020โ‚ฌ79.06 M17.26%
2019โ‚ฌ67.42 M223.91%
2018โ‚ฌ20.81 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ6.59 M-92.89%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ69.64 M-24.94%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ82.08 B 88,367.13%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ58.80 B 63,272.51%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.6 M-99.35%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.64 B 598.17%๐Ÿ‡บ๐Ÿ‡ธ USA